A practical reference on GHRH analogue: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-09-13 and is reviewed periodically as new material appears.
Enzymatic protection is a separate mechanism from plasma protein binding. The four substitutions in the backbone reduce recognition by dipeptidyl peptidase IV, which normally cleaves the natural hormone within minutes. Without the reactive group, this resistance still yields only a short window of activity, generally reported in the range of tens of minutes. With it, reported half-lives in early human work extended to several days. The size of that gap is the main practical distinction between the two materials.
Both forms act at the pituitary receptor for growth hormone-releasing hormone and increase growth hormone output, which in turn raises insulin-like growth factor 1. A long-acting analog produces sustained rather than pulsatile stimulation, and the physiological consequences of that pattern are not fully settled. Published human data on the extended form remain limited, and much of what circulates in discussion traces to early company reports rather than independent replication. How sustained exposure affects normal feedback remains an open question.
The distinguishing feature of the DAC form is a maleimide-containing group that reacts with the free thiol of cysteine-34 on human serum albumin. This reaction forms a covalent bond without enzymatic assistance, and it takes place after the peptide enters the bloodstream. Because albumin is abundant and long-lived, the attached peptide is carried through circulation far longer than an unmodified fragment would survive. The chemistry is a deliberate pharmacokinetic strategy rather than a change to receptor activity.
Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.
The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.
| Property | Value | Notes |
|---|---|---|
| Duration with linker | Several days | Reported in early human work |
| Duration without linker | Tens of minutes | Short plasma residence |
| Albumin attachment site | Cysteine-34 | Covalent maleimide reaction |
| Primary receptor | Pituitary GHRH receptor | Stimulates growth hormone release |
| Downstream marker | Insulin-like growth factor 1 | Indirect measure of activity |
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
The second form adds a maleimide-bearing linker to the lysine at the carboxyl end. This group reacts with cysteine-34 on circulating serum albumin, forming a covalent bond that keeps the peptide in the bloodstream for far longer. ConjuChem developed the molecule as a way to extend the action of a peptide without frequent administration. The albumin attachment is the defining structural feature of the drug affinity complex version. Whether continuous exposure produces effects distinct from shorter pulses remains an unresolved research question.
CJC-1295 belongs to a class of synthetic peptides modeled on growth hormone releasing hormone, a forty-four amino acid signal produced by the hypothalamus. The compound is built from the first twenty-nine residues of the natural sequence, with four substitutions introduced at positions 2, 8, 15 and 27. These changes were designed to slow enzymatic breakdown while preserving receptor activation. The result is a peptide that is shorter than native GHRH and considerably more resistant to ordinary clearance pathways in circulation.
Two related forms appear under the CJC-1295 name. The simpler analogue, commonly written as modified GRF(1-29), carries the four substitutions but no additional conjugation. The second form attaches a maleimidopropionic acid linker to a lysine residue, a modification frequently called the drug affinity complex. That linker reacts with the free thiol on serum albumin to form a covalent bond. Because albumin has a long residence time in blood, the conjugated peptide stays in circulation far longer than the unconjugated analogue.
CJC-1295 is a synthetic peptide belonging to the growth hormone-releasing hormone analog family. It comprises twenty-nine amino acid residues derived from the N-terminal region of natural GHRH. The molecule incorporates several non-natural substitutions that increase resistance to enzymatic degradation. These modifications extend its activity compared with the native hormone fragment. Researchers use it to study pituitary growth hormone secretion in laboratory and clinical settings. This compound is distinct from native GHRH in its stability profile.
Two principal forms appear in the literature and in research supply. One carries a drug affinity complex, a maleimide-based group that forms a covalent bond with circulating albumin. This linkage slows clearance and produces a long-lasting elevation of peptide levels. The other form lacks that group and is often labeled MOD GRF(1-29). It has a much shorter circulation time. Both variants retain the same core receptor-binding sequence. Reported half-lives differ substantially between the two.
At the pituitary, the peptide binds the growth hormone-releasing hormone receptor on somatotroph cells. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone. Somatostatin and other hypothalamic signals modulate this response. Negative feedback from insulin-like growth factor 1 also influences output. The same regulatory architecture operates with the native hormone. Whether the synthetic analog alters feedback dynamics over repeated exposure remains an open question. Most published receptor work uses cell models rather than intact human systems.
Duck and Cover, a 1951 educational movie explaining what to do in the event of a nuclear attack. Five, a 1951 film about five survivors, one woman and four men, of an atomic war that has wiped out the rest of the human race (while leaving all infrastructure intact). The five come together at a remote, isolated hillside house in Southern California, where they try to figure out how to survive while also being forced to face an unknown future. On the Beach (1959) depicted a gradually dying, post-apocalyptic world in Australia that remained after a nuclear Third World War. The Mouse on the Moon (1963) a comedy satire about, the people of the Duchy of Grand Fenwick, a microstate in Europe, attempt space flight using wine as a propellant. It satirises the space race, Cold War and politics. Ladybug Ladybug (1963) an elementary school nuclear bomb warning alarm sounds. Dr. Strangelove or: How I Learned to Stop Worrying and Love the Bomb (1964) – A black comedy film that satirizes the Cold War and the threat of nuclear warfare. Fail-Safe (1964) – A film based on a novel of the same name about an American bomber crew and nuclear tensions. The War Game (BBC, 1965; aired 1985) – Depicts the effects of a nuclear war in Britain following a conventional war that escalates to nuclear war. Damnation Alley (20th Century Fox, 1977) – Surprise ICBM attack launched on the United States, and the subsequent efforts of a small band of survivors from a missile silo in the Mojave Desert in California to reach another group of survivors in Albany, New York.
Tofu has also been fused into other cuisines in the West, for instance in Indian-style curries. Tofu and soy protein can be industrially processed to match the textures and flavors of cheese, pudding, eggs, bacon, and similar products. Tofu's texture can also be altered by freezing, puréeing, and cooking. In the Americas, Europe, Australia and New Zealand, tofu is frequently associated with vegetarianism and veganism, as it is a source of non-animal protein. In India, tofu is used as a low-fat replacement for paneer, providing a similar texture. Awara (also known as wara soya, Nigerian tofu, or Beske), is a food commonly consumed in Northern Nigeria. It's produced by curdling soy milk with a natural agent, then pressing, seasoning, and frying it into cubes. As opposed to an ingredient substitute, the tofu is eaten as the main ingredient, often with vegetables on the side.
=== Qualitative filter paper === Qualitative filter paper is used in qualitative analytical techniques to determine materials. There are different grades of qualitative filter paper according to different pore size. There are total 13 different grades of qualitative filter paper. The largest pore size is grade 4; the smallest pore size is grade 602 h; the most commonly used grades are grade 1 to grade 4.
T4 (levothyroxine) is almost always preferred over T3 (liothyronine) when treating hypothyroidism. Treatment with T3 alone is not recommended, as it causes increased and potentially unsafe blood levels of free T3 (FT3). Combination treatment of hypothyroidism with T4 and T3 is generally only considered when treatment with T4 alone does not sufficiently resolve symptoms. As there is no evidence showing that combination treatment with T4 and T3 benefits patients, this approach is controversial, but it is supported by current guidelines of the European Thyroid Association and the British Thyroid Association for patients who do not respond at all to treatment with T4 alone.
This was reported in most of mainland Europe and the UK which led to a price increase of approximately 30 percent in the cost of street heroin and increased demand for diverted methadone. The number of addicts seeking treatment also increased significantly during this period. Other heroin droughts (shortages) have been attributed to cartels restricting supply in order to force a price increase and also to a fungus that attacked the opium crop of 2009. Many people thought that the American government had introduced pathogens into the Afghanistan atmosphere in order to destroy the opium crop and thus starve insurgents of income. On 13 March 2012, Haji Bagcho, with ties to the Taliban, was convicted by a US District Court of conspiracy, distribution of heroin for importation into the United States and narco-terrorism. Based on heroin production statistics compiled by the United Nations Office on Drugs and Crime, in 2006, Bagcho's activities accounted for approximately 20 percent of the world's total production for that year.
Sources: en.wikipedia.org
One mode of monazite formation is crystallization from an igneous melt. The concentric zoning pattern reflects the changing composition of the melt which affects the composition of the crystallizing monazite.
== See also == RO5073012 – TAAR1 weak partial agonist RO5166017 – TAAR1 partial or full agonist RO5256390 – TAAR1 partial or full agonist RO5263397 – TAAR1 partial agonist EPPTB – TAAR1 antagonist/inverse agonist
As of July 2024, lisdexamfetamine is the only pharmacotherapy approved by the US Food and Drug Administration (FDA) and the Therapeutic Goods Administration for BED. Evidence indicates that its effectiveness in treating BED may be partially due to a psychopathological overlap with attention deficit hyperactivity disorder, a cognitive-control disorder that also benefits from treatment with lisdexamfetamine. Medical reviews of randomized controlled trials have established that lisdexamfetamine, administered at doses between 50 and 70 mg, is safe and effective for treating BED. These reviews consistently report fewer weekly binge eating episodes. Furthermore, a meta-analytic systematic review included a 12-month study showing the medication was effective for a long period of time. Two reviews have found lisdexamfetamine to be superior to placebo in several secondary outcomes, including persistent binge eating cessation and reductions in obsessive-compulsive binge eating symptoms, body weight, and triglycerides. Lisdexamfetamine is a pharmacologically inert prodrug that confers its therapeutic effects for BED after conversion to its active metabolite, dextroamphetamine, which acts in the central nervous system. Dextroamphetamine increases the availability of dopamine and norepinephrine in the prefrontal cortex, which makes major decision-making for the body. Lisdexamfetamine, like all pharmaceutical amphetamines, possesses direct appetite suppressant effects, which may be therapeutically beneficial for BED and its associated comorbidities.
The sample may be introduced into the column at any time during the column equilibration step or after equilibration has been accomplished. After the volume of eluant surpasses the volume of the mobile phase in the column, the sample components will begin to elute. Compounds with a partition coefficient of unity will elute when one column volume of mobile phase has passed through the column since the time of injection. The compound can then be introduced to another stationary phase to help increase the resolution of results. The flow is stopped after the target compound(s) are eluted or the column is extruded by pumping the stationary phase through the column. An example of a major application of countercurrent chromatography is to take an extremely complex matrix such as a plant extract, perform the countercurrent chromatography separation with a carefully selected solvent system, and extrude the column to recover all of the sample. The original complex matrix will have been fractionated into discrete narrow polarity bands, which may then be assayed for chemical composition or bioactivity. Performing one or more countercurrent chromatography separations in conjunction with other chromatographic and non chromatographic techniques has the potential for rapid advances in compositional recognition of extremely complex matrices.
Sources: en.wikipedia.org
=== COSMIC: Identification confidence === The COSMIC confidence score assigns a confidence to CSI:FingerID structure identifications. The idea is similar to False Discovery Rates: All molecules in a large dataset are analysed using CSI:FingerID, the top-ranked hit for each molecule will be evaluated by COSMIC and the most trustworthy identifications can be selected for further analysis. COSMIC does not re-rank structure candidates of a particular molecule nor does it discard any identifications. COSMIC employs a confidence score that combines E-value estimation and a linear support vector machine (SVM) with enforced directionality. Calibration of CSI:FingerID scores is achieved using E-value estimates. Generating decoys for small molecule structures is a non-trivial task, that is why candidates in PubChem serve as a proxy for decoys here. The score distribution is modeled as a mixture distribution of log-normal distributions, and the P-value and E-value of a hit score are estimated using the kernel density estimate of PubChem candidate scores. The SVM is employed to classify whether a hit is correct, utilizing features such as the calibrated score, score differences to other candidates, the total peak intensity explained by the fragmentation tree, and the cardinality of molecular fingerprints. Learning is constrained to a linear SVM to mitigate the risk of overfitting, and the directionality of features is enforced. This involves making upfront decisions about whether high or low values of a feature should enhance the confidence in an identification.
In Britain, think tanks play a similar role to the United States, attempting to shape policy, and indeed there is some cooperation between British and American think tanks. For example, the London-based think tank Chatham House and the Council on Foreign Relations were both conceived at the Paris Peace Conference, 1919 and have remained sister organisations. The Bow Group, founded in 1951, is the oldest centre-right think tank and many of its members have gone on to serve as Members of Parliament or Members of the European Parliament. Past chairmen have included Conservative Party leader Michael Howard, Margaret Thatcher's longest-serving Cabinet Minister Geoffrey Howe, Chancellor of the Exchequer Norman Lamont and former British Telecom chairman Christopher Bland. Since 2000, a number of influential centre-right think tanks have emerged including Policy Exchange, Centre for Social Justice and most recently Onward.
=== Diversity, equity, and inclusion === Gallrein is opposed to the idea of diversity, equity, and inclusion and believes that these principles should be removed from schools, the military, and the government.
Sources: en.wikipedia.org
A maleimide moiety reacts with the thiol of cysteine-34, forming a covalent bond. The reaction occurs in circulation without enzymatic catalysis.
The group is intended to alter distribution and persistence, not receptor engagement. The peptide portion still binds the pituitary receptor, so the primary difference is duration rather than potency.
Not firmly. Early reports describe several days for the extended form, but independent confirmations are sparse, and values vary with assay method and study design.
The two share the same 29-amino-acid backbone. CJC-1295 carries an additional albumin-binding moiety that markedly extends its residence time in circulation, while the form without that moiety clears faster. Literature sometimes applies the name loosely to either variant.